Russian cancer vaccine release timeline revealed

Russian scientists are finalising work on a new, groundbreaking cancer vaccine due to be released next year, according to Alexander Gintsburg, the head of the Gamaleya Research Institute of Epidemiology and Microbiology.

The Gamaleya Center created the Sputnik V Covid-19 inoculation in August 2020, one of the first to be developed in the world.

Gintsburg made the remarks in an interview with RT’s Roman Kosarev on Tuesday, linking the cancer drug breakthrough to the rapid development of Covid vaccination methods. Seven patents have already been treated, he said, adding that the technology was fully domestically developed.

Work on the new vaccine was a multi-stage process. It started around the middle of 2022 when researchers realised that the mRNA technology underlying many Covid vaccines held great promise, according to Gintsburg.

The new drug is a therapeutic vaccine to be administered to those already diagnosed with cancer, the Gamaleya chief said. It causes the patient’s immune system to start destroying malignant cells. The shot enables Cytotoxic lymphocytes, or white blood cells, that appear in the body of a vaccinated person to recognize foreign proteins (antigens) on the surface of tumor cells. Cytotoxic lymphocytes then find foreign, metastasizing cells and destroy them throughout the body.

RT

The post Russian cancer vaccine release timeline revealed appeared first on DailyNews.